Filter Results:
(488)
Show Results For
- All HBS Web (655)
- Faculty Publications (317)
Show Results For
- All HBS Web (655)
- Faculty Publications (317)
Sort by
- August 2003
- Teaching Note
Pharmacyclics: Financing Research and Development (TN)
By: Malcolm P. Baker and Richard S. Ruback
Teaching Note for (9-201-056). View Details
- September 1986
- Case
BOC Group: Ohmeda (A)
The president of Ohmeda, a wholly owned company of the BOC Group, plans to grow the company's medical equipment sales from $95 million in 1985 to $158 million in five years by focusing on the sale of "high-tech" equipment. At the same time, the president expects to... View Details
Keywords: Marketing Communications; Salesforce Management; Marketing Channels; Medical Devices and Supplies Industry
Moriarty, Rowland T., Jr. "BOC Group: Ohmeda (A)." Harvard Business School Case 587-080, September 1986.
- September 2016
- Article
Value Based Care and Bundled Payments: Anesthesia Care Costs for Outpatient Oncology Surgery Using Time-driven Activity-based Costing
By: Katy E. French, Alexis B. Guzman, Augustin C. Rubio, John C. Frenzel and Thomas Feeley
Background:
With the movement towards bundled payments, stakeholders should know the true cost of the care they deliver. Time-driven activity-based costing (TDABC) can be used to estimate costs for each episode of care. In this analysis, TDABC is used to both... View Details
French, Katy E., Alexis B. Guzman, Augustin C. Rubio, John C. Frenzel, and Thomas Feeley. "Value Based Care and Bundled Payments: Anesthesia Care Costs for Outpatient Oncology Surgery Using Time-driven Activity-based Costing." Healthcare: The Journal of Delivery Science and Innovation 4, no. 3 (September 2016): 173–180.
- 10 Jan 2005
- Research & Ideas
Motivation and the Cross-Sector Alliance
government blames the industrial sector, thus holding manufacturers responsible. The upcoming period of legislative meetings will tackle the new law on containers and packages. There are several proposals,... View Details
- January 2014 (Revised December 2014)
- Case
GenapSys: Business Models for the Genome
By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble
GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details
Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation & Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States
Hamermesh, Richard G., Joseph B. Fuller, and Matthew Preble. "GenapSys: Business Models for the Genome." Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
- 21 Jun 2010
- Research & Ideas
Strategy and Execution for Emerging Markets
challenge is to understand local customer needs and produce localized products. In our book we discuss companies including GE, which has been innovating in the medical sector, View Details
Keywords: by Martha Lagace
- October 2024
- Case
Allurion: Competing in the Age of GLP-1
By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso
Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details
- March 2000 (Revised May 2003)
- Teaching Note
Owens & Minor, Inc. (A) and (B) TN
By: V.G. Narayanan and Lisa Brem
Teaching Note for (9-100-055) and (9-100-079). View Details
- April 2013
- Case
Southfield Packaging
By: Michael Beer and Alisa Zalosh
Southfield Packaging provides packaging materials and services to medical device manufacturers. The case examines the relationship between a corporate vice president, Mark Sanders, and one of his direct reports, Regional Manager Frank Belby. Sanders' preparation for... View Details
Keywords: Rank and Position; Performance Evaluation; Problems and Challenges; Management Teams; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry
Beer, Michael, and Alisa Zalosh. "Southfield Packaging." Harvard Business School Brief Case 913-562, April 2013.
- Research Summary
Overview
Navid has worked with different organizations across various industries, from the Federal Reserve to medical device manufacturers, heavy construction equipment sellers, and B2B software providers, to assemble proprietary datasets in studying organizational buying.... View Details
- November 2021 (Revised December 2024)
- Case
Kermit PPI
By: Kyle Myers, Matt Grennan and Sarah Mehta
Launched in 2011, Kermit PPI helped hospitals save money on expensive orthopedic implants and devices by enabling them to renegotiate their contracts with device manufacturers and better monitor compliance. In 2021, as they look to grow, they are entertaining two... View Details
Keywords: Health; Health Care and Treatment; Strategy; Expansion; Information Technology; Applications and Software; Supply Chain; Supply Chain Management; Contracts; Health Industry; Health Industry; Health Industry; United States; Maryland
Myers, Kyle, Matt Grennan, and Sarah Mehta. "Kermit PPI." Harvard Business School Case 622-007, November 2021. (Revised December 2024.)
- February 2002 (Revised August 2002)
- Case
Inhale Therapeutics: Executing and Growing the Business Model
Inhale is about to bring a novel technology to market that uses inhalation to administer drugs that formerly required injection. Inhale must now decide which way to evolve its business model. This will determine the future direction of growth for the company. View Details
Keywords: Business Model; Technological Innovation; Health Care and Treatment; Growth and Development Strategy; Medical Devices and Supplies Industry
Chesbrough, Henry W., and Gillian Morris. "Inhale Therapeutics: Executing and Growing the Business Model." Harvard Business School Case 602-132, February 2002. (Revised August 2002.)
- 25 Sep 2018
- First Look
New Research and Ideas, September 25, 2018
from Medical Device Recalls By: Ball, George P., Jeffrey T. Macher, and Ariel Dora Stern Abstract—When innovations are successfully commercialized into new products, they can... View Details
Keywords: Dina Gerdeman
- 31 Aug 2021
- Book
Feeling Powerless at Work? Time to Agitate, Innovate, and Orchestrate
and children by not only providing medical care, but also working to rehabilitate people’s homes and provide vocational training for parents. She initially shied away from... View Details
Keywords: by Jay Fitzgerald
- September 2012 (Revised September 2012)
- Course Overview Note
Building Life Science Businesses Fall 2012: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses View Details
- March 2013
- Teaching Plan
Corruption at Siemens (TP) (A), (B), (C) and (D)
By: Paul Healy
This teaching plan is designed to be used in conjunction with the case Corruption at Siemens (A), HBS No. 108033 [and its related B and C cases] to help faculty deepen students' comprehension of business issues and to energize classroom discussion. View Details
Healy, Paul. "Corruption at Siemens (TP) (A), (B), (C) and (D)." Harvard Business School Teaching Plan 113-092, March 2013.
- April 2004 (Revised June 2004)
- Case
Entrepreneurship Goes Global: ResMed's Gamble
By: Christopher A. Bartlett, Andrew N. McLean and Meg Glinska
On the basis of its innovative medical device for treating sleep apnea, CEO Peter Farrell has made Australian-born ResMed a successful global company. But the company is struggling to implement a strategy to expand the device from its focused core market to a much... View Details
Keywords: Business Model; Globalization; Innovation and Management; Management; Marketing Channels; Production; Expansion; Medical Devices and Supplies Industry
Bartlett, Christopher A., Andrew N. McLean, and Meg Glinska. "Entrepreneurship Goes Global: ResMed's Gamble." Harvard Business School Case 304-051, April 2004. (Revised June 2004.)
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
labor between innovative new entrants and industry incumbents, endowed with complementary assets, is common in many industries. Such settings are distinct because new entrants have the additional option to... View Details
Keywords: Dina Gerdeman
- August 2013
- Course Overview Note
Building Life Science Businesses Fall 2013: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses. View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Health Industry; Health Industry; Asia; North America; Europe
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
- February 2020
- Teaching Note
Theranos: Who Has Blood on Their Hands? (A) and (B)
By: Nien-he Hsieh and Christina R. Wing
Teaching Note for HBS Nos. 619-039 and 320-091. View Details